An explainable AI system for automated COVID-19 assessment and lesion categorization from CT-scans.


Journal

Artificial intelligence in medicine
ISSN: 1873-2860
Titre abrégé: Artif Intell Med
Pays: Netherlands
ID NLM: 8915031

Informations de publication

Date de publication:
08 2021
Historique:
received: 25 09 2020
revised: 06 05 2021
accepted: 12 05 2021
entrez: 20 8 2021
pubmed: 21 8 2021
medline: 26 8 2021
Statut: ppublish

Résumé

COVID-19 infection caused by SARS-CoV-2 pathogen has been a catastrophic pandemic outbreak all over the world, with exponential increasing of confirmed cases and, unfortunately, deaths. In this work we propose an AI-powered pipeline, based on the deep-learning paradigm, for automated COVID-19 detection and lesion categorization from CT scans. We first propose a new segmentation module aimed at automatically identifying lung parenchyma and lobes. Next, we combine the segmentation network with classification networks for COVID-19 identification and lesion categorization. We compare the model's classification results with those obtained by three expert radiologists on a dataset of 166 CT scans. Results showed a sensitivity of 90.3% and a specificity of 93.5% for COVID-19 detection, at least on par with those yielded by the expert radiologists, and an average lesion categorization accuracy of about 84%. Moreover, a significant role is played by prior lung and lobe segmentation, that allowed us to enhance classification performance by over 6 percent points. The interpretation of the trained AI models reveals that the most significant areas for supporting the decision on COVID-19 identification are consistent with the lesions clinically associated to the virus, i.e., crazy paving, consolidation and ground glass. This means that the artificial models are able to discriminate a positive patient from a negative one (both controls and patients with interstitial pneumonia tested negative to COVID) by evaluating the presence of those lesions into CT scans. Finally, the AI models are integrated into a user-friendly GUI to support AI explainability for radiologists, which is publicly available at http://perceivelab.com/covid-ai. The whole AI system is unique since, to the best of our knowledge, it is the first AI-based software, publicly available, that attempts to explain to radiologists what information is used by AI methods for making decisions and that proactively involves them in the decision loop to further improve the COVID-19 understanding.

Identifiants

pubmed: 34412837
pii: S0933-3657(21)00107-X
doi: 10.1016/j.artmed.2021.102114
pmc: PMC8139171
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102114

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Références

Sci Rep. 2020 Jan 15;10(1):338
pubmed: 31941918
Lancet. 2020 Feb 15;395(10223):e30-e31
pubmed: 32032529
Radiology. 2020 Aug;296(2):E65-E71
pubmed: 32191588
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):1027-1031
pubmed: 32634717
J Travel Med. 2020 Aug 20;27(5):
pubmed: 32437541
Comput Methods Programs Biomed. 2020 Nov;196:105608
pubmed: 32599338
Wiley Interdiscip Rev Data Min Knowl Discov. 2019 Jul-Aug;9(4):e1312
pubmed: 32089788
Eur Radiol Exp. 2020 Aug 20;4(1):50
pubmed: 32814998
Neuroimage. 2019 Jul 1;194:1-11
pubmed: 30898655
Radiology. 2020 Apr;295(1):202-207
pubmed: 32017661
IEEE Trans Med Imaging. 2018 Dec;37(12):2572-2581
pubmed: 29993538
Biomed J. 2020 Aug;43(4):355-362
pubmed: 32426387
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Sci Rep. 2017 Aug 18;7(1):8738
pubmed: 28821822
IEEE Trans Med Imaging. 2018 Nov;37(11):2428-2440
pubmed: 29993996
IEEE Trans Cybern. 2020 Jul;50(7):2891-2904
pubmed: 32396126
BMC Med Inform Decis Mak. 2020 Jan 6;20(1):4
pubmed: 31906931
Comput Methods Biomech Biomed Eng Imaging Vis. 2018;6(1):1-6
pubmed: 29623248
Radiol Cardiothorac Imaging. 2020 Feb 13;2(1):e200034
pubmed: 33778547
Radiology. 2020 Sep;296(3):E156-E165
pubmed: 32339081
J Infect. 2020 May;80(5):e7-e13
pubmed: 32171865
IEEE Rev Biomed Eng. 2021;14:4-15
pubmed: 32305937
Nat Commun. 2020 Jul 15;11(1):3543
pubmed: 32669540
Croat Med J. 2020 Jul 5;61(3):279-288
pubmed: 32643346
Med Phys. 2011 Feb;38(2):915-31
pubmed: 21452728
Healthcare (Basel). 2020 Feb 27;8(1):
pubmed: 32120822
Nat Med. 2020 Aug;26(8):1224-1228
pubmed: 32427924
IEEE Trans Med Imaging. 2016 May;35(5):1160-1169
pubmed: 26955024
Radiol Cardiothorac Imaging. 2020 Mar 30;2(2):e200075
pubmed: 33778562
Radiology. 2020 Apr;295(1):22-23
pubmed: 32049600
IEEE Trans Med Imaging. 2016 May;35(5):1285-98
pubmed: 26886976

Auteurs

Matteo Pennisi (M)

DIEEI, University of Catania, Catania, Italy.

Isaak Kavasidis (I)

DIEEI, University of Catania, Catania, Italy. Electronic address: kavasidis@dieei.unict.it.

Concetto Spampinato (C)

DIEEI, University of Catania, Catania, Italy.

Vincenzo Schinina (V)

National Institute for infectious disease, "Lazzaro Spallanzani" Department, Rome, Italy.

Simone Palazzo (S)

DIEEI, University of Catania, Catania, Italy.

Federica Proietto Salanitri (FP)

DIEEI, University of Catania, Catania, Italy.

Giovanni Bellitto (G)

DIEEI, University of Catania, Catania, Italy.

Francesco Rundo (F)

STMicroelectronics - ADG Central R&D, Catania, Italy.

Marco Aldinucci (M)

Department of Computer Science, University of Turin, Turin, Italy.

Massimo Cristofaro (M)

National Institute for infectious disease, "Lazzaro Spallanzani" Department, Rome, Italy.

Paolo Campioni (P)

National Institute for infectious disease, "Lazzaro Spallanzani" Department, Rome, Italy.

Elisa Pianura (E)

National Institute for infectious disease, "Lazzaro Spallanzani" Department, Rome, Italy.

Federica Di Stefano (F)

National Institute for infectious disease, "Lazzaro Spallanzani" Department, Rome, Italy.

Ada Petrone (A)

National Institute for infectious disease, "Lazzaro Spallanzani" Department, Rome, Italy.

Fabrizio Albarello (F)

National Institute for infectious disease, "Lazzaro Spallanzani" Department, Rome, Italy.

Giuseppe Ippolito (G)

National Institute for infectious disease, "Lazzaro Spallanzani" Department, Rome, Italy.

Salvatore Cuzzocrea (S)

ChimBioFaram Department, University of Messina, Messina, Italy.

Sabrina Conoci (S)

ChimBioFaram Department, University of Messina, Messina, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH